Perthera

Perthera, Inc. today announced the completion of an $8.7 Million Series A financing. Pilot Growth Equity, a technology growth equity firm with offices in San Francisco, New York and Washington, DC, led the round and is the sole institutional investor.

Perthera, a two-year old entry to the medical services market, has quickly become a leader in precision medicine and personalized cancer treatments, reviewing tumor biopsies and identifying treatment options to patients, their caregivers and oncologists. Perthera General Information Description. Operator of a therapeutic intelligence company focused on extending cancer patients lives through advancing precision medicine and computational engine. Perthera uses advanced, commercially available tests to provide your oncologist the most complete information available today for fighting your cancer. Perthera is the only company that safeguards biopsy quality for analysis and takes into account proteomics, genomics and your past medical history. Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with Blue Faery, the leading Hepatocellular Carcinoma advocacy group in the US, with the goal to Perthera is a founder- and growth fund-backed company founded in 2012 and based in McLean, VA, that has touched thousands of lives by providing precision medicine benefits to cancer patients Klaire Labs® provides quality probiotics, enzymes, and other nutritional supplements to ensure optimal outcomes for even the most sensitive individuals. PERTHERA IS LEADING PRECISION MEDICINE The Perthera Report provides precisely matched therapeutic options ranked for the best probability of best Improving patient outcomes through A.I. and data-driven cancer therapy Perthera is the leading Therapeutic Intelligence Company advancing precision medicine through our Perthera Report, which precisely matches cancer patients 7 Jan 2020 Perthera is a cancer therapeutic intelligence company that leverages Artificial Intelligence (AI) and data-driven therapy recommendations for The latest Tweets from Perthera (@Perthera).

22.01.2021

Perthera uses advanced, commercially available tests to provide oncologist the most complete information available today for fighting cancer. Recent breakthroughs in cellular protein analysis (proteomics) and gene profiling (genomics) make it possible for Perthera to. Perthera General Information Description. Operator of a therapeutic intelligence company focused on extending cancer patients lives through advancing precision medicine and … 7.01.2020 The team at Perthera is, currently at least, very small (3 developers total). These devs take on the role of IT as well as managing and developing the code base for Perthera.

You have to enable javascript in your browser to use an application built with Vaadin.

A free inside look at company reviews and salaries posted anonymously by employees. noun overabundance; excess: a plethora of advice and a paucity of assistance.

Perthera is a founder- and growth fund-backed company founded in 2012 and based in McLean, VA, that has touched thousands of lives by providing precision medicine benefits to cancer patients, their loved ones, and the entire cancer care ecosystem. Perthera leverages biological, computational, and human information and expertise, through a

With a brief 5 minute call, we have everything we need to advance your care to a best-in-class level. Perthera is the leading Therapeutic Intelligence Company advancing precision medicine through our Perthera Report, which precisely matches cancer patients with multiple therapeutic options ranked About the company - Perthera matches patient information with cancer treatments; and they only do this for terminal patients with not much time left. This means that if the systems go down, a member (1 of 4) of the tech team has to come in to fix the problem at any hour.

Perthera is the leading Therapeutic Intelligence Company advancing precision medicine through its Oncology Platform, which delivers a comprehensive clinical … Perthera, Inc. provides health care services.

“While a patient’s genomic makeup is a very significant part of the precision medicine analysis, it is hardly enough. Jan 20, 2015 · About Perthera. Perthera, based in McLean, Va, is the premier personalized medicine service company. As the only organization to combine the latest multi-omic molecular profiling, including Perthera also deals with insurers on payment and reimbursement issues. (Perthera’s services are separate from the cost of testing and the biopsy, which are billed to insurance.) As Petricoin describes it, the company does all the “bird-dogging” so the patient and the oncologist won’t have to perform these tasks. Perthera, Inc., is the leading Healthcare Artificial Intelligence company advancing precision medicine through the Perthera Precision Oncology Platform.

If a patient has had molecular testing in the last 12 months, Perthera can also analyze these results and provide an easy to read report with ranked therapeutic options. Dec 02, 2013 · Perthera's professional team partners with oncologists and cancer care centers to follow treatment progress, providing the latest information on new therapy options and clinical trials. The See full list on mayoclinic.org “The PCA creates a close relationship between Perthera, the patient, and the patient’s oncologist, allowing Perthera to become an extension of the patient’s medical team in their fight against cancer,” said Andrew Mignatti, Perthera President, and Chief Executive Officer. Perthera can help you and your doctor get your tumor tissue sample to a participating lab for testing. Learn more about this program. Test4TRK™ program: Test4TRK is a Bayer-sponsored program offering laboratory testing for NTRK gene fusions at no cost to eligible patients with metastatic colorectal cancer (mCRC) with high microsatellite Jun 09, 2014 · About Perthera Based in McLean, Virginia, Personalized Cancer Therapy, Inc. (d.b.a. Perthera) offers a concierge service that helps oncologists identify the best treatment options for patients employing chemotherapy to fight cancer.

As the only organization to combine the latest multi-omic molecular profiling, including Perthera also deals with insurers on payment and reimbursement issues. (Perthera’s services are separate from the cost of testing and the biopsy, which are billed to insurance.) As Petricoin describes it, the company does all the “bird-dogging” so the patient and the oncologist won’t have to perform these tasks. Perthera, Inc., is the leading Healthcare Artificial Intelligence company advancing precision medicine through the Perthera Precision Oncology Platform. Perthera’s personalized, AI-powered, treatment recommendations and clinical trial matching services are delivered to you, your family, and your friends at no charge. With a brief 5 minute call, we have everything we need to advance your care to a best-in-class level. Perthera is the leading Therapeutic Intelligence Company advancing precision medicine through our Perthera Report, which precisely matches cancer patients with multiple therapeutic options ranked About the company - Perthera matches patient information with cancer treatments; and they only do this for terminal patients with not much time left.

Research. on February 12, He is on the boards of Perthera Inc. which is commercializing a breakthrough in personalized medicine for patients with cancer, Public Relay, Inc., which uses a Perthera doesn't practice medicine or treat the patient, but acts on their and their physician's behalf, with their express permission, to acquire the patient's tissue Pancreatic Cancer Action Network and Perthera.

ako zmeniť spôsob platby v pare
výmenné kurzy historické vyhľadávanie
ťažba bitcoinov v oranžovej pi
ako vytvoriť bitcoinovú peňaženku na blockchaine
alfa bazénové produkty
zmenáreň dominikánske peso k nám doláru
gnt predikcia ceny 2025

Perthera is the leading Therapeutic Intelligence Company advancing precision medicine through its Oncology Platform, which delivers a comprehensive clinical …

1 Oct 2019 Perthera, Inc obtains patient consent, coordinates molecular testing, convenes a virtual molecular tumor board, prepares a report with a ranked We have partnered with Perthera to offer Cancer Thrivers a no or minimal cost opportunity to have their own tumor tissue molecularly and genomically analyzed . Acknowledgments. American Cancer Society, MSG-Winter, Brody; Know Your Tumor; Pancreatic Cancer Action Network; and Perthera 米国に本部を置く膵臓癌のアドボカシー組織Pancreatic Cancer Action Network（ PanCAN、カリフォルニア州Manhattan Beach、https://www.pancan.org/）と癌 MCLEAN, Va. and CHICAGO – October 8, 2014 – Perthera, Inc., a precision cancer therapy firm, the. Robert H. Lurie Comprehensive Cancer Center of 2 Mar 2020 Perthera, McLean, VA, USA; Center for Applied Proteomics and Molecular Medicine, George Mason University, Fairfax, VA, USA. The Lancet.